A registry study led by the University of Oulu examined the early-stage treatment of relapsing-remitting multiple sclerosis (MS) in Finland between 2013 and 2022. According to the study, MS treatment ...

A simple treatment algorithm may help reduce treatment disparities for Hispanic and Black people with multiple sclerosis (MS), according to a preliminary study released today, March 3, 2025, that will ...

Experts in multiple sclerosis discuss the potential introduction of a subcutaneous form of ocrelizumab to the market in late 2024 and how they plan to incorporate it into their treatment algorithms.

Heidi Crayton, MD, and Maria Lopes, MD, discuss the most recent 2018 guidelines for multiple sclerosis treatment, emphasizing the need for updated guidelines, particularly in the payer space, to ...

Multiple Sclerosis is a chronic degenerative disease of the central nervous system characterized by inflammatory demyelination and axonal transection. There is no single test for diagnosing Multiple ...

A novel program provided evidence that addressing long-known disparities in high-efficacy multiple sclerosis (MS) treatment for minority populations is a solvable problem. The program, presented by ...

Anti-CD20 therapies and S1P receptor modulators seem to be equally effective for most people with late-onset MS, a real-world ...

Does MS cause pain? Should people with MS exercise? Many common beliefs about MS aren’t true, but here we separate fact from fiction.